FCN-338
N/A
Report date: 2025/06/09 17:38:15
NME
Base Information
Drug NameFCN-338
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFochon Pharmaceuticals Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesEli Lilly And CompanyFochon Pharmaceuticals LtdShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Inactive CompaniesN/A
Active Indications +[10]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A